Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, California, USA
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Thorax. 2020 Jan;75(1):17-27. doi: 10.1136/thoraxjnl-2019-213803. Epub 2019 Nov 8.
Survivors of critical illness often experience poor outcomes after hospitalisation, including delayed return to work, which carries substantial economic consequences.
To conduct a systematic review and meta-analysis of return to work after critical illness.
We searched PubMed, Embase, PsycINFO, CINAHL and Cochrane Library from 1970 to February 2018. Data were extracted, in duplicate, and random-effects meta-regression used to obtain pooled estimates.
Fifty-two studies evaluated return to work in 10 015 previously employed survivors of critical illness, over a median (IQR) follow-up of 12 (6.25-38.5) months. By 1-3, 12 and 42-60 months' follow-up, pooled return to work prevalence (95% CI) was 36% (23% to 49%), 60% (50% to 69%) and 68% (51% to 85%), respectively (=0.55, I=87%, p=0.03). No significant difference was observed based on diagnosis (acute respiratory distress syndrome (ARDS) vs non-ARDS) or region (Europe vs North America vs Australia/New Zealand), but was observed when comparing mode of employment evaluation (in-person vs telephone vs mail). Following return to work, 20%-36% of survivors experienced job loss, 17%-66% occupation change and 5%-84% worsening employment status (eg, fewer work hours). Potential risk factors for delayed return to work include pre-existing comorbidities and post-hospital impairments (eg, mental health).
Approximately two-thirds, two-fifths and one-third of previously employed intensive care unit survivors are jobless up to 3, 12 and 60 months following hospital discharge. Survivors returning to work often experience job loss, occupation change or worse employment status. Interventions should be designed and evaluated to reduce the burden of this common and important problem for survivors of critical illness.
PROSPERO CRD42018093135.
危重病幸存者在住院后常常预后不良,包括延迟重返工作岗位,这会带来巨大的经济后果。
对危重病后重返工作岗位进行系统回顾和荟萃分析。
我们从 1970 年至 2018 年 2 月在 PubMed、Embase、PsycINFO、CINAHL 和 Cochrane Library 进行了检索。数据由两人独立提取,并采用随机效应荟萃回归来获得汇总估计值。
52 项研究评估了 10015 名曾有工作的危重病幸存者的重返工作岗位情况,中位(IQR)随访时间为 12(6.25-38.5)个月。在 1-3、12 和 42-60 个月的随访时,汇总的重返工作岗位率(95%CI)分别为 36%(23%-49%)、60%(50%-69%)和 68%(51%-85%)(=0.55,I=87%,p=0.03)。按诊断(急性呼吸窘迫综合征(ARDS)与非 ARDS)或地区(欧洲、北美与澳大利亚/新西兰)分组,差异无统计学意义,但按就业评估方式(面对面、电话、邮件)分组,差异有统计学意义。重返工作岗位后,20%-36%的幸存者失业,17%-66%的幸存者职业发生变化,5%-84%的幸存者就业状况恶化(例如,工作时间减少)。延迟重返工作的潜在危险因素包括既往合并症和住院后受损(例如心理健康)。
大约三分之二、五分之二和三分之一的曾有工作的重症监护病房幸存者在出院后 3、12 和 60 个月时无工作。重返工作的幸存者常常失业、职业改变或就业状况恶化。应设计和评估干预措施,以减少危重病幸存者这一常见且重要问题的负担。
PROSPERO CRD42018093135。